The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2021 | Improving global accessibility of myeloma treatment
Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, talks on improving the accessibility of treatment for patients with myeloma worldwide, highlighting the global efforts from organizations such as the International Myeloma Society to make treatments like chimeric antigen receptor (CAR) T-cell therapy available globally. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
Disclosures
Noopur Raje, MD, has participated in consulting for Amgen, BMS, GSK, Janssen, Takeda, Oncopeptides, Karyopharm, Bluebird Bio, Pfizer, AstraZeneca; has participated in the advisory boards of Immuneel and Caribou; and has received research funding from Bluebird Bio,
